Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study-February 2024-www.financetom.com

Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study

Jun 3, 2024 3:53 AM

June 3 (Reuters) - Agios Pharmaceuticals ( AGIO ) said

on Monday its experimental treatment for an inherited blood

disorder met the main goal in a late-stage study.

Previous page： Meta's Instagram down for thousands, Downdetector shows Next page： Ecopetrol's Reficar refinery awarded nearly 20% of McDermott common capital, company says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Meta's Instagram down for thousands, Downdetector shows

Mar 21, 2024

March 21 (Reuters) - Meta Platforms's ( META ) Instagram was down for thousands of users on Thursday, according to outage tracking website Downdetector.com. ...

Ecopetrol's Reficar refinery awarded nearly 20% of McDermott common capital, company says

Mar 21, 2024

BOGOTA, March 21 (Reuters) - The Reficar oil refinery belonging to Colombia's Ecopetrol was awarded 19.9% of the common capital in infrastructure firm McDermott in preferential shares by a judge in Amsterdam, Ecopetrol said in a statement on Thursday. The refinery is located in the Colombian city of Cartagena. ...

Oil eases on possible Gaza ceasefire, dollar strength

Mar 21, 2024

SINGAPORE (Reuters) -Oil prices slipped on Friday on the possibility of a nearing Gaza ceasefire that could ease geopolitical concerns in the Middle East, while a stronger dollar and faltering U.S. gasoline demand also weighed on prices. Brent crude futures fell 42 cents, or 0.5%, to $85.36 a barrel by 0203 GMT. U.S. crude futures shed 40 cents, or 0.5%,...

Hong Kong-listed Samsonite plans dual listing in hunt for investors

Mar 21, 2024

(Reuters) -Luggage maker Samsonite International ( SMSOF ) on Friday said it plans to pursue a dual listing in addition to its listing on the Hong Kong Stock Exchange to increase the liquidity of its shares and reach investors in more markets. Samsonite ( SMSOF ) did not provide details of the exchanges it is considering for the second listing,...